Exhibit 2
AGREEMENT REGARDING THE JOINT FILING OF
SCHEDULE 13D
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
In accordance with Rule13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D with respect to the Common Stock beneficially owned by each of them of Keros Therapeutics, Inc. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13D.
Date: April 23, 2020
PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. | ||
By : | /s/ Ran Nussbaum | |
Name: | Ran Nussbaum | |
Title: | Chief Executive Officer | |
PONTIFAX (CAYMAN) IV, L.P. | ||
By: | /s/ Ran Nussbaum | |
Name: | Ran Nussbaum | |
Title: | Chief Executive Officer | |
PONTIFAX (ISRAEL) IV, L.P. | ||
By: | /s/ Ran Nussbaum | |
Name: | Ran Nussbaum | |
Title: | Chief Executive Officer | |
PONTIFAX (CHINA) IV L.P. | ||
By: | /s/ Ran Nussbaum | |
Name: | Ran Nussbaum | |
Title: | Chief Executive Officer | |
PONTIFAX LATE STAGE FUND L.P. | ||
By : | /s/ Asaf Shinar | |
Name: | Asaf Shinar | |
Title : | Chief Financial Officer | |
PONTIFAX LATE STAGE GP Ltd. | ||
By : | /s/ Asaf Shinar | |
Name: | Asaf Shinar | |
Title : | Chief Financial Officer |